Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study

By Costanzo F.D.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 2, 1999-03 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

By Johnston S.   Gumbrell L.   Evans T.   Coleman R.   Smith I.   Twelves C.   Soukop M.   Rea D.   Earl H.   Howell A.   Jones A.   Canney P.   Powles T.   Haynes B.   Nutley B.   Grimshaw R.   Jarman M.   Halbert G.   Brampton M.   Haviland J.   Dowsett M.   Coombes R.  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 341-348

Springer Publishing Company

Access to resources Recommend Favorite

Randomised Phase II Study of Epirubicin-Vindesine Versus Mitoxantrone-Vindesine in Metastatic Breast Cancer

By Hausmaninger H.   Lehnert M.   Steger G.   Sevelda P.   Tschurtschenthaler G.   Hehenwarter W.   Fridrik M.   Samonigg H.   Schiller L.   Manfreda D.   Haidinger R.   Kienzer R.   Kemmler G.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2169-2173

Elsevier

Access to resources Recommend Favorite

A randomized phase II non-comparative study of pemetrexedcarboplatin and gemcitabinevinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients

By                    

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1778-1785

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

By Cooper Brenda   Radivoyevitch Tomas   Overmoyer Beth   Shenk Robert   Pham Huong   Samuels Judith   Parry Margaret   Silverman Paula  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 311-318

Springer Publishing Company

Access to resources Recommend Favorite